Record ID | marc_columbia/Columbia-extract-20221130-005.mrc:357165755:3313 |
Source | marc_columbia |
Download Link | /show-records/marc_columbia/Columbia-extract-20221130-005.mrc:357165755:3313?format=raw |
LEADER: 03313pam a2200445 a 4500
001 2277711
005 20220616010454.0
008 990119t19991999nyua b 001 0 eng c
010 $a 99011315
020 $a0824702379 (alk. paper)
035 $a(OCoLC)40738878
035 $a(OCoLC)ocm40738878
035 $9APC3557CU
035 $a(NNC)2277711
035 $a2277711
040 $aDNLM/DLC$cDLC$dDLC$dOrLoB-B
050 00 $aRS201.S57$bP64 1999
060 10 $aW1$bDR893B v.95 1999
060 10 $aQV 744$bP783 1999
082 00 $a615/.19$221
245 00 $aPolymorphism in pharmaceutical solids /$cedited by Harry G. Brittain.
260 $aNew York :$bM. Dekker,$c[1999], ©1999.
300 $aix, 427 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aDrugs and the pharmaceutical sciences ;$vv. 95
504 $aIncludes bibliographical references and index.
505 00 $g1.$tTheory and Origin of Polymorphism /$rDavid J. W. Grant --$g2.$tApplication of the Phase Rule to the Characterization of Polymorphic Systems /$rHarry G. Brittain --$g3.$tStructural Aspects of Polymorphism /$rHarry G. Brittain and Stephen R. Byrn --$g4.$tStructural Aspects of Hydrates and Solvates /$rKenneth R. Morris --$g5.$tGeneration of Polymorphs, Hydrates, Solvates, and Amorphous Solids /$rJ. Keith Guillory --$g6.$tMethods for the Characterization of Polymorphs and Solvates /$rHarry G. Brittain --$g7.$tEffects of Polymorphism and Solid-State Solvation on Solubility and Dissolution Rate /$rHarry G. Brittain and David J. W. Grant --$g8.$tEffects of Pharmaceutical Processing on Drug Polymorphs and Solvates /$rHarry G. Brittain and Eugene F. Fiese --$g9.$tStructural Aspects of Molecular Dissymmetry /$rHarry G. Brittain --$g10.$tImpact of Polymorphism on the Quality of Lyophilized Products /$rMichael J. Pikal.
520 $aProviding essential information on the myriad physical properties that a single given compound may exhibit, Polymorphism in Pharmaceutical Solids presents a comprehensive examination of polymorphic behavior in pharmaceutical development - demonstrating with clear, practical examples how to navigate complicated crystal structures.
520 8 $aThis superb compendium is essential reading for industrial and product development pharmacists; pharmaceutical scientists; medicinal, physical, surface, colloid, and analytical chemists and spectroscopists; and professional seminars and graduate-level courses in these disciplines.
650 0 $aSolid dosage forms.$0http://id.loc.gov/authorities/subjects/sh85124623
650 0 $aPolymorphism (Crystallography)$0http://id.loc.gov/authorities/subjects/sh85104682
650 0 $aSolvation.$0http://id.loc.gov/authorities/subjects/sh85124742
650 0 $aHydration.$0http://id.loc.gov/authorities/subjects/sh85063294
650 12 $aChemistry, Pharmaceutical.$0https://id.nlm.nih.gov/mesh/D002626
650 22 $aMolecular Structure.$0https://id.nlm.nih.gov/mesh/D015394
650 22 $aCrystallization.$0https://id.nlm.nih.gov/mesh/D003460
700 1 $aBrittain, H. G.$0http://id.loc.gov/authorities/names/n93097233
830 0 $aDrugs and the pharmaceutical sciences ;$vv. 95.$0http://id.loc.gov/authorities/names/n42009973
852 00 $boff,eng$hRS201.S57$iP64 1999